The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma

D. Tas, F. Ciftci, O. Deniz, E. Tozkoparan (Diyarbakir, Istanbul, Erzurum, Turkey)

Source: Annual Congress 2001 - Asthma monitoring and therapy
Session: Asthma monitoring and therapy
Session type: Thematic Poster Session
Number: 1810
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Tas, F. Ciftci, O. Deniz, E. Tozkoparan (Diyarbakir, Istanbul, Erzurum, Turkey). The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma. Eur Respir J 2001; 16: Suppl. 31, 1810

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients?
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002

Serum eosinophil cationic protein as a marker of disease severity in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001

Comparisons of the eosinophil cationic protein (ECP) levels and eosinophil counts in sputum of mustard lung disease (MLD) and normal subjects
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009


Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018

Theophylline drip infusion reduces peripheral blood eosinophil counts and ECP (eosinophil cationic protein) level on acute exacerbation of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 108s
Year: 2002

Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 584s
Year: 2005

Role of sputum eosinophil levels in the assessment of asthma treatment
Source: Eur Respir J 2004; 24: Suppl. 48, 579s
Year: 2004

Influence of moderate altitude and endurance challenge on serum eosinophil cationic protein (ECP), eosinophil dynamics and lung function
Source: Eur Respir J 2001; 18: Suppl. 33, 368s
Year: 2001

Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005

Mycoplasma pneumoniae infection affects total eosinophil count, the serum level of ECP, and interleukin-5 in atopic children
Source: Annual Congress 2012 - Airway infections in children: from risk factors to treatment
Year: 2012

Serum levels of interleukin-18 in patients affected by allergic bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 30s
Year: 2002

Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002

Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum
Source: Eur Respir J 2002; 20: Suppl. 38, 143s
Year: 2002

Serum high sensitivity C-reactive protein can distinguish cough-variant and bronchial asthma
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008



The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 114s
Year: 2002

Eotaxin in serum and sputum: comparison between normal and allergic asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 163s
Year: 2004

Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response
Source: Eur Respir J 2003; 22: 118-126
Year: 2003



Serum concentration of C-reactive protein is not a good marker of bronchial hyperreactivity
Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy
Year: 2007


Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005